LYRA THERAPEUTICS INC

CUSIP: 55234L105 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 434,226 Value ($000) $55 Avg Close Range
Q4 2024
Shares 424,965 Value ($000) $88 Avg Close Range
Q3 2024
Shares 24,915 Value ($000) $6 Avg Close Range
Q2 2024
Shares 14,697 Value ($000) $4 Avg Close Range
Q1 2024
Shares 18 Value ($000) $0 Avg Close Range
Q4 2023
Shares 4,800 Value ($000) $25 Avg Close Range
Q3 2023
Shares 18 Value ($000) $0 Avg Close Range
Q2 2023
Shares 18 Value ($000) $0 Avg Close Range
Q1 2023
Shares 853 Value ($000) $2 Avg Close Range
Q4 2022
Shares 3,397 Value ($000) $11 Avg Close Range
Q3 2022
Shares 3,094 Value ($000) $15 Avg Close Range
Q2 2022
Shares 2,022 Value ($000) $11 Avg Close Range
Q1 2022
Shares 18 Value ($000) $0 Avg Close Range
Q4 2021
Shares 4,070 Value ($000) $18 Avg Close Range
Q3 2021
Shares 18 Value ($000) $0 Avg Close Range
Q2 2021
Shares 567 Value ($000) $5 Avg Close Range
Q1 2021
Shares 2,754 Value ($000) $32 Avg Close Range
Q4 2020
Shares 3,617 Value ($000) $41 Avg Close Range
Q3 2020
Shares 848 Value ($000) $9 Avg Close Range
Q2 2020
Shares 1,716 Value ($000) $19 Avg Close Range